---
figid: PMC11671260__fmed-11-1490314-g002
figtitle: Multiple drug treatments that interfere with the gut microbiota
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC11671260
filename: fmed-11-1490314-g002.jpg
figlink: /pmc/articles/PMC11671260/figure/F2/
number: F2
caption: Multiple drug treatments that interfere with the gut microbiota. Prebiotics
  inhibites Toll-like receptor/nuclear factor kappa-B (TLR/NF-κB) signaling pathway
  and phosphatidylinositol-3-kinase-protein Kinase B (PI3K-AKT) pathway. They reduce
  the production of pro-inflammatory factors, and repaired the tight junction between
  intestinal epithelium. Methanolic extract of Moutan Cortex (MC) reduces Inhibitor-κBα
  (I-κBα) phosphorylation and NF-κB activation in macrophages by inhibiting lipopolysaccharide
  (LPS), thereby inhibiting inducible nitric oxide synthase (iNOS) and Cyclooxygenase-2
  (COX-2) expression, and decreasing concentrations of tumor necrosis factor-α (TNF-α),
  interleukin (IL)-1β, and IL-6. MC polysaccharides can reshape the intestinal flora
  to produce more short-chain fatty acids (SCFA) in diabetic kidney disease (DKD)
  rat model, and reduce serum inflammatory factors and alleviate kidney injury in
  the process
papertitle: Research progress of gut microbiome and diabetic nephropathy
reftext: Chenling Chu, et al. Front Med (Lausanne). 2024;11(NA).
year: '2024'
doi: 10.3389/fmed.2024.1490314
journal_title: Frontiers in Medicine
journal_nlm_ta: Front Med (Lausanne)
publisher_name: Frontiers Media SA
keywords: diabetic nephropathy | gut microbiota | short-chain fatty acids | inflammation
  | enteric-renal axis | probiotics
automl_pathway: 0.914517
figid_alias: PMC11671260__F2
figtype: Figure
redirect_from: /figures/PMC11671260__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11671260__fmed-11-1490314-g002.html
  '@type': Dataset
  description: Multiple drug treatments that interfere with the gut microbiota. Prebiotics
    inhibites Toll-like receptor/nuclear factor kappa-B (TLR/NF-κB) signaling pathway
    and phosphatidylinositol-3-kinase-protein Kinase B (PI3K-AKT) pathway. They reduce
    the production of pro-inflammatory factors, and repaired the tight junction between
    intestinal epithelium. Methanolic extract of Moutan Cortex (MC) reduces Inhibitor-κBα
    (I-κBα) phosphorylation and NF-κB activation in macrophages by inhibiting lipopolysaccharide
    (LPS), thereby inhibiting inducible nitric oxide synthase (iNOS) and Cyclooxygenase-2
    (COX-2) expression, and decreasing concentrations of tumor necrosis factor-α (TNF-α),
    interleukin (IL)-1β, and IL-6. MC polysaccharides can reshape the intestinal flora
    to produce more short-chain fatty acids (SCFA) in diabetic kidney disease (DKD)
    rat model, and reduce serum inflammatory factors and alleviate kidney injury in
    the process
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - IRAK4
  - MYD88
  - FFAR3
  - FFAR2
  - HCAR2
  - NFKB1
  - PYY
  - AKT1
  - AKT2
  - AKT3
  - NOS2
  - ISYNA1
  - PTGS2
  - RELA
  - RELB
  - REL
  - NFKB2
  - GCG
  - GLP1R
  - ZGLP1
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - ITK
  - SLC22A3
  - irak4
  - myd88
  - pyya
  - COX2
  - Polysaccharide
  - SCFAs
  - GLP-1
  - proteinuria
  - renal fibrosis
---
